ZWJ Investment Counsel Inc. reduced its position in Aetna Inc. (NYSE:AET) by 0.3% during the second quarter, Holdings Channel reports. The institutional investor owned 7,655 shares of the company’s stock after selling 24 shares during the period. ZWJ Investment Counsel Inc.’s holdings in Aetna were worth $1,162,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Blair William & Co. IL increased its position in shares of Aetna by 31.2% in the second quarter. Blair William & Co. IL now owns 19,737 shares of the company’s stock worth $2,997,000 after buying an additional 4,699 shares in the last quarter. Pegasus Partners Ltd. increased its position in shares of Aetna by 2.8% in the second quarter. Pegasus Partners Ltd. now owns 7,426 shares of the company’s stock worth $1,127,000 after buying an additional 205 shares in the last quarter. Penobscot Investment Management Company Inc. increased its position in shares of Aetna by 2.2% in the second quarter. Penobscot Investment Management Company Inc. now owns 11,400 shares of the company’s stock worth $1,731,000 after buying an additional 250 shares in the last quarter. KBC Group NV increased its position in shares of Aetna by 42.9% in the second quarter. KBC Group NV now owns 226,420 shares of the company’s stock worth $34,378,000 after buying an additional 68,028 shares in the last quarter. Finally, Ballentine Partners LLC increased its position in shares of Aetna by 10.5% in the second quarter. Ballentine Partners LLC now owns 2,519 shares of the company’s stock worth $391,000 after buying an additional 239 shares in the last quarter. Institutional investors and hedge funds own 91.69% of the company’s stock.

Shares of Aetna Inc. (AET) opened at 154.45 on Friday. The company’s 50-day moving average is $154.81 and its 200-day moving average is $140.38. The stock has a market cap of $51.29 billion, a PE ratio of 34.28 and a beta of 0.54. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter in the previous year, the business posted $2.21 EPS. The firm’s revenue was down 2.7% on a year-over-year basis. Equities analysts anticipate that Aetna Inc. will post $9.55 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Aetna Inc. (AET) Shares Sold by ZWJ Investment Counsel Inc.” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/08/19/aetna-inc-aet-shares-sold-by-zwj-investment-counsel-inc.html.

A number of brokerages have commented on AET. Morgan Stanley upped their target price on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research note on Thursday. Cantor Fitzgerald restated an “overweight” rating and issued a $175.00 target price (up from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Deutsche Bank AG upped their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Jefferies Group LLC restated a “hold” rating and issued a $163.00 target price (up from $157.00) on shares of Aetna in a research note on Friday, August 4th. Finally, Royal Bank Of Canada upped their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research note on Friday, August 4th. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Aetna has an average rating of “Buy” and a consensus price target of $157.99.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.